RYBELSUS
NOVO NORDISK CANADA INC
Quick answers
Is there a shortage of RYBELSUS in Canada?
No. There is no current shortage of RYBELSUS 4MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Ozempic and GLP-1 Shortage in Canada: Current Status
Why Ozempic and other GLP-1 medications have cycled in and out of shortage in Canada, how to check the current status, and what to ask your pharmacist if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SEVMIA
APOTEX INC
RYBELSUS
NOVO NORDISK CANADA INC
WEGOVY
NOVO NORDISK CANADA INC
PLOSBRIO
NOVO NORDISK CANADA INC
OZEMPIC
NOVO NORDISK CANADA INC
SANDOZ SEMAGLUTIDE
SANDOZ CANADA INCORPORATED
DIN
02551020
Strength
4MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NOVO NORDISK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02249405
DIN 02309009
2100UNIT · DIN 02546221
700UNIT · DIN 02546205
1050UNIT · DIN 02546213
500UNIT · DIN 02490064
2000UNIT · DIN 02490099
1000UNIT · DIN 02490072
3000UNIT · DIN 02490102
100UNIT · DIN 02460408
100UNIT · DIN 02460416
100UNIT · DIN 02460424